
Andrew Powaleny is Senior Director of Public Affairs at PhRMA and leads the organization's scientific communications, national advocacy events and grassroots initiative, Voters for Cures. He also helped found and currently co-chairs The PRIDE Umbrella, PhRMA’s employee resource group for LGBTQ+ colleagues. Before joining PhRMA in 2015, Andrew worked in public affairs for a small firm in Washington, DC and served as Deputy Press Secretary for the House Committee on Energy and Commerce. Andrew came to Washington, D.C. via Connecticut with a degree from Eastern Connecticut State University where he majored in public policy and government. Andrew is active as a runner and volunteer with the DC Front Runners; and served on its Board of Directors for three years as co-race director. He is also a member of the NLGJA: The Association of LGBTQ Journalists, singer with The Gay Men’s Chorus of Washington, and mentors students through his alumni association with The Fund for American Studies. Andrew is passionate about scientific innovation, especially for mental illness, and his heroes are the men and women of America’s biopharmaceutical research companies.
Recent Posts
Recognizing LGBTQ+ Pride in biopharmaceutical science

Report: More than 500 medicines in development to treat disorders of the blood

ICYMI: PhRMA CEO Stephen J. Ubl spotlights lessons learned during COVID-19

The accelerated approval pathway: Helping patients with serious or life-threatening diseases

4 things to know about biopharmaceutical efforts to fight cancer

New data show continued decline in death rates for cancer patients related to treatment advances

Post-approval research save lives. Why is Congress trying disincentivize it?

New Report: Nearly 800 new medicines in development to treat rare diseases

3 things to know about the importance of post-approval research and development

World AIDS Day: Remembering those we’ve lost and exploring the continued fight against HIV/AIDS
